Geroprotectors as a therapeutic strategy for COPD – where are we now?

Although current therapies in chronic obstructive pulmonary disease (COPD) improve the quality of life, they do not satisfactorily reduce disease progression or mortality. There are still many gaps in knowledge about the cellular, molecular, and genetic mechanisms contributing to pathobiology of thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Miłkowska-Dymanowska, Joanna, Białas, Adam J, Makowska, Joanna, Wardzynska, Aleksandra, Górski, Paweł, Piotrowski, Wojciech J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5661461/
https://www.ncbi.nlm.nih.gov/pubmed/29123386
http://dx.doi.org/10.2147/CIA.S142483

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5661461/
https://www.ncbi.nlm.nih.gov/pubmed/29123386
http://dx.doi.org/10.2147/CIA.S142483

Ejemplares similares